Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 2000, p. 348-354, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Candida albicans Mutants Deficient in Respiration Are
Resistant to the Small Cationic Salivary Antimicrobial Peptide
Histatin 5
Csilla
Gyurko,1
Urs
Lendenmann,1
Robert F.
Troxler,1,2 and
Frank G.
Oppenheim1,2,*
Department of Periodontology and Oral
Biology, Boston University Goldman School of Dental
Medicine1 and Department of
Biochemistry, Boston University School of
Medicine,2 Boston, Massachusetts 02118-2392
Received 22 July 1999/Returned for modification 22 September
1999/Accepted 25 October 1999
 |
ABSTRACT |
Histatins are a group of small cationic peptides in human saliva
which are well known for their antibacterial and antifungal activities.
In a previous study we demonstrated that histatin 5 kills both
blastoconidia and germ tubes of Candida albicans in a time-
and concentration-dependent manner at 37°C, whereas no killing was
detected at 4°C. This indicated that killing activity depends on
cellular energy. To test histatin 5 killing activity at lower cellular
ATP levels at 37°C, respiratory mutants, or so-called petite mutants,
of C. albicans were prepared. These mutants are deficient
in respiration due to mutations in mitochondrial DNA. Mutants were
initially identified by their small colony size and were further
characterized with respect to colony morphology, growth
characteristics, respiratory activity, and cytochrome spectra. The
killing activity of histatin 5 at the highest concentration was only 28 to 30% against respiratory mutants, whereas 98% of the wild-type
cells were killed. Furthermore, histatin 5 killing activity was also
tested on wild-type cells in the presence of the respiratory inhibitor
sodium azide or, alternatively, the uncoupler carbonyl cyanide
m-chlorophenylhydrazone. In both cases histatin 5 killing
activity was significantly reduced. Additionally, supernatants and
pellets of cells incubated with histatin 5 in the presence or absence
of inhibitors of mitochondrial ATP synthesis were analyzed by sodium
dodecyl sulfate gel electrophoresis. It was observed that wild-type
cells accumulated large amounts of histatin 5, while wild-type cells
treated with inhibitors or petite mutants did not accumulate
significant amounts of the peptide. These data showed first that
cellular accumulation of histatin 5 is necessary for killing activity
and second that accumulation of histatin 5 depends on the availability
of cellular energy. Therefore, mitochondrial ATP synthesis is required
for effective killing activity of histatin 5.
 |
INTRODUCTION |
Candida albicans is a
dimorphic yeast which can switch between the blastospore form and one
of several filamentous forms referred to as germ tubes, pseudohyphae,
and hyphae (24, 25). This fungus is frequently found in the
oral flora of healthy individuals. A comprehensive analysis of
publications on oral yeast carriage revealed that the frequency of
C. albicans in the oral cavity ranges between 2 and 69%
(median, 24.5%) in healthy adults and between 41 and 54% (median,
44.0%) in infants of ages between 1 week and 18 months
(24). Various systemic and local factors such as
malnutrition, immunodeficiencies, endocrine disorders, malignant
diseases, radiation therapy, xerostomia, and denture wearing can
predispose humans to Candida infections (24, 26, 33).
The fact that a majority of the individuals carrying Candida
in the oral cavity do not develop candidiasis demonstrates that host
defense systems prevent development of this disease under normal
conditions. Saliva appears to play a crucial role in this function,
because patients with decreased saliva secretion, due to
Sjögren's syndrome or as a consequence of radiation treatment for head and neck cancer, often develop oral candidiasis (1, 4,
22, 30, 31). Among the many proteins secreted into human parotid
and submandibular-sublingual saliva, the family of histatins may play
an important role in maintaining oral health. The major members of the
histatin family are histatins 1, 3, and 5, containing 38, 32, and 24 amino acids, respectively (27, 37). They are cationic due to
a high content of the basic amino acids lysine and arginine. In a
recent clinical study, histatin concentrations in salivary secretions
of individuals not harboring oral C. albicans were found to
be significantly higher than those of healthy carriers (15).
This suggests that histatins may prevent candidiasis in vivo, and
indeed, in vitro studies have shown that these peptides kill C. albicans very effectively (27, 29, 43). Therefore,
elucidation of the antifungal mechanism of histatins may contribute to
understanding the role of saliva in oral homeostasis.
In a previous study, we found that histatin 5, which is the most active
of all histatins, killed both C. albicans blastoconidia and
germ tubes in a time- and concentration-dependent manner at 37°C but
not at 4°C (C. Gyurko, U. Lendenmann, M. S. Lamkin, C. Champagne, R. F. Troxler, and F. G. Oppenheim, J. Dent. Res., abstr. 1443, 77:286, 1998). These results suggested that killing activity may depend on metabolic activity of the cells. Therefore, carrying out C. albicans killing assays under
conditions where mitochondrial ATP synthesis cannot take place could be
a powerful tool to determine the role of cellular energy in the antifungal activity of histatin 5. In yeast, oxidative phosphorylation can be abolished by suppressing mitochondrial ATP synthesis with specific inhibitors or by inducing respiratory mutations. Sodium azide
inhibits cytochrome oxidase, and therefore, the cells are restricted to
nonoxidative pathways for ATP synthesis (16, 42). Alternatively, carbonyl cyanide m-chlorophenylhydrazone
(CCCP), an uncoupler of membrane proton gradients, stops ATP synthesis without blocking oxygen uptake by the cells (13, 41).
Indeed, it was recently described that sodium azide and CCCP protected C. albicans from the antifungal activity of histatin 5. However, the results could not conclusively answer whether the
protection was due to mitochondrial dysfunction, because cellular ATP
levels were not reduced by treatment of cells with these inhibitors
(18). An additional indication of a mitochondrial role in
killing activity was provided by colocalization experiments with
fluorescently labeled histatin 5 and a mitochondrion-specific probe
that identified the mitochondria as an intracellular target of histatin
5 (12). Limitations on the use of metabolic inhibitors or
fluorescent probes are their toxic side effects on microbial cells.
Therefore, the role of mitochondria in the susceptibility of C. albicans to histatin 5 can be identified only if their function is
abolished without treating cells with metabolic inhibitors.
Yeasts offer the unique opportunity that mutants deficient in
mitochondrial respiration can be isolated. For Saccharomyces cerevisiae such petite mutants have been known for a long time (8), but petite mutants of C. albicans were
thought not to be viable (5). However, recent work indicates
that petite mutants of C. albicans can be used to study a
host of biological questions related to mitochondrial function (2,
3, 14, 32). Such mutants form only tiny, so-called petite,
colonies because their cell division rates are lower than that of the
normal cells and their biomass yield on glucose is decreased (8,
34, 36). The growth of petite mutants is limited to fermentable
carbon sources such as glucose or sucrose, but they fail to grow on
glycerol and ethanol (2, 34). Cytochrome determinations show
that petite mutants are lacking either cytochrome b or
cytochrome aa3 or both but always retain
cytochrome c (6, 10, 35). The molecular basis of
the petite phenotype is mutation or deletion of mitochondrial genes
(9).
In this study we successfully induced petite mutation by culturing
C. albicans in the presence of acriflavine at an elevated temperature of 42°C. The mutants obtained were thoroughly
characterized with respect to growth pattern, cytochrome spectrum, and
respiratory activity. Subsequently, the killing activity of histatin 5 was tested with the petite mutants, and the results were compared to
those obtained with wild-type cells in the presence of sodium azide or
CCCP. Additionally, the cellular uptake of histatin 5 was determined
with wild-type, sodium azide-treated wild-type, and petite cells.
 |
MATERIALS AND METHODS |
Yeast culture.
The strains used in this study were C. albicans ATCC 44505 and petite mutants 1 and 2, which were
isolated following mutagenesis of C. albicans ATCC 44505. Cells were maintained on Sabouraud dextrose agar (SDA) (Difco, Detroit,
Mich.).
Induction and isolation of respiratory mutants.
Petite
mutants were obtained according to a procedure published by Aoki and
Ito-Kuwa in 1987 (3). C. albicans wild-type cells
were grown on an SDA plate overnight at 37°C. A colony was transferred into an Erlenmeyer flask containing 100 ml of liquid yeast-peptone-glucose (YPG) medium consisting of (per liter) 10 g
of yeast extract, 20 g of peptone (both from Difco), and 20 g
of glucose. Acriflavine was added to the cell suspension at a final
concentration of 100 µg · ml
1, and subsequently,
the flask was incubated at 42°C. After cells reached stationary
phase, the culture was centrifuged, washed, plated onto glucose-limited
agar plates, and incubated at 37°C for 5 days. Small colonies were
selected and transferred onto glucose- and glycerol-limited agar
plates. Glucose-limited agar plates contained (per liter) 20 g of
peptone, 10 g of yeast extract, 10 g of glucose, 10 g of
glycerol, and 15 g of agar, while in glycerol-limited plates
glucose was omitted and the glycerol concentration was increased to 40 g · liter
1. After incubation at 37°C for 5 days,
colonies growing only on glucose- but not on glycerol-limited agar
plates were selected and used for further studies.
Growth and colony characteristics.
The growth patterns of
the petite mutants and the wild-type parent strain were compared in YPG
medium at 30°C with constant shaking at 200 rpm. At various time
intervals, growth was measured spectrophotometrically (Spectronic 1201;
Milton-Roy Londonderry, N.H.) at 600 nm. Detection of
respiration-deficient cells was carried out with glucose-limited and
glycerol-limited agar plates which were incubated at 37°C for 72 h. For color-based identification of respiration-deficient mutants,
cells were grown on indicator plates containing (per liter) 1.5 g
of KH2PO4, 1.5 g of
(NH4)2SO4, 1 g of
MgSO4 · H2O, 1.5 g of peptone,
1.5 g of yeast extract, 20 g of glucose, 0.01 g of eosin
Y, 0.01 g of trypan blue, and 15 g of agar (23).
Cytochrome spectra.
Yeast cells were grown in 500 ml of YPG
medium at 37°C, collected by centrifugation, washed with distilled
water, and resuspended in 6 to 10 ml of water to give a dense cell
slurry. Aliquots of cell suspensions were used for spectral analysis
with a dual-beam U-2000 spectrophotometer (Hitachi Instruments Inc.,
Stoughton, Mass.) as described previously (6).
Respiration measurements.
C. albicans wild-type cells
and mutant cells deficient in respiration were grown on SDA plates at
37°C for 24 and 72 h, respectively. Colonies were
collected, washed with sterile water, and centrifuged, and the pellet
was resuspended in 5 ml of 10 mM potassium phosphate buffer (pH 7.4)
(PPB) to give a cell density of 5 × 106 cells
· ml
1. Oxygen consumption by the cells was measured at
37°C with a biological oxygen monitor (model-5300; Yellow Springs
Instrument, Yellow Springs, Ohio). Initially, endogenous oxygen
consumption was measured, and subsequently, effects of addition of
glucose, sodium azide (Fisher Scientific, Fair Lawn, N.J.), and CCCP
(Sigma, St. Louis, Mo.) were measured at final concentrations of 30 mM, 25 mM, and 100 µM, respectively. Respiration rates were calculated from triplicate experiments and are expressed as nanomoles of O2 · milliliter
1 · minute
1.
Killing assay.
Candida killing assays were performed
with wild-type blastoconidia and petite mutants 1 and 2 as described
previously (43). Briefly, C. albicans wild-type
and petite cells were grown on SDA plates at 37°C for 24 and 72 h, respectively. Colonies were suspended in 10 ml of 10 mM PPB (pH 7.4)
and diluted to give a cell density of approximately 105
cells · ml
1. Aliquots of 50 µl of cell
suspension were added to the wells of a microtiter plate, and cells
were allowed to attach for 15 min. Subsequently, 50-µl portions of
histatin test solutions (in PPB) were added to the wells, and the
microtiter plate was incubated for 60 min at 37°C. To test the effect
of inhibitors of mitochondrial ATP synthesis, cells were suspended in
PPB containing sodium azide (25 mM) or CCCP (100 µM) and killing
assays were carried out with histatin test solutions containing the
same concentrations of these inhibitors. In separate control
experiments sodium azide (25 mM) and CCCP (100 µM) were evaluated for
their toxicity towards C. albicans in the absence of
histatin 5. After 60 min of incubation, wells were washed three times
with PPB and 100 µl of molten Sabouraud dextrose broth (45°C)
containing 2% agarose were added to each well. Subsequently, wild-type
cells were incubated for 5 to 6 h and petite mutant cells were
incubated for 16 to 18 h at 30°C. Under these conditions,
surviving cells divide and form colonies, while dead cells remain as
single cells. A colony was defined as a cluster of more than five
contiguous cells. To estimate killing activity, a total of 100 dead
cells or live colonies were counted with an inverted microscope and the
results were expressed as percentage of killed cells per total number
of cells. Killing assays were carried out in triplicates.
Interaction of wild-type and petite cells with histatin 5.
Wild-type and petite cells were grown in YPG liquid medium at 30°C.
Exponentially growing cells were centrifuged, washed three times with
distilled water, and resuspended in 10 mM PPB to a concentration of
approximately 107 cells · ml
1 as
measured by optical density at 530 nm. Wild-type cells were also
resuspended in 10 mM PPB containing 25 mM sodium azide to test effects
of respiration inhibitors on the interactions of histatin 5 with cells.
Cell suspensions of 1 ml were incubated with histatin 5 at 65 nmol
· ml
1 (200 µg · ml
1) at 37°C
for 60 min. In control experiments, cells were incubated with buffer
alone. Cells were pelleted at 10,000 × g for 2 min, and the supernatant was collected, recentrifuged, and filtered (type HV
filter, 0.45-µm pore size; Millipore, Bedford, Mass.). The pellets
were washed twice with PPB and suspended in 200 µl of PPB containing
a protease inhibitor cocktail consisting of AEBSF
[4-(2-aminoethyl)-benzenesulfonylfluoride], aprotinin, E-64, EDTA,
and leupeptin (Calbiochem-Novabiochem Corp., La Jolla, Calif.). Glass
beads (425 to 600 µm; Sigma) were added to the cell suspension, and
cells were disrupted by three 1-min bursts in a Bead Beater-8 Chamber
(BioSpec Products, Bartlesville, Okla.). Subsequently, proteins in
supernatants and lysates of cell pellets were examined by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 16%
gels and stained with 0.4% Coomassie brilliant blue R250.
 |
RESULTS |
Characterization of petite mutants.
Petite mutation was
induced by growing C. albicans cells at 42°C to stationary
phase in the presence of acriflavine. A sample of the culture was
plated on glucose-limited agar plates, and several hundred colonies
that were significantly smaller than average were selected and tested
for their ability to grow on glucose- and glycerol-limited agar plates.
Approximately 0.5% of the colonies that grew with glucose failed to
grow on glycerol-limited agar plates, indicating a petite phenotype.
Two of these colonies were designated petites 1 and 2 and were used for
further studies.
The growth patterns of wild-type and petite 1 and 2 cells were examined
on glucose- and glycerol-limited agar plates. Within 24-h, wild-type
cells grew well on both glucose-limited (Fig. 1A) and glycerol-limited (Fig. 1B)
plates. In contrast, even after 72 h, petites 1 and 2 formed only
tiny colonies on glucose-limited agar (Fig. 1C) and completely failed
to grow on plates containing only glycerol as a carbon source (Fig.
1D). Further confirmation of respiratory deficiency in petites 1 and 2 was obtained on indicator plates containing eosin Y and trypan blue. On
this medium, wild-type cells formed large, pale-bluish colonies,
whereas the petite mutants formed only small, deep-violet colonies
(Fig. 2). The specific growth rates for
the wild type and petites 1 and 2 in liquid YPG medium were 0.54, 0.07, and 0.06 h
1, respectively. The corresponding optical
densities at 600 nm of the cultures at stationary phase were
approximately 5 times higher for the wild type than for mutant cells.
These results showed that petite mutants grow approximately 10 times
slower and form 5 times less biomass than wild-type cells. This growth pattern is similar to that of petite mutants of S. cerevisiae (36).

View larger version (143K):
[in this window]
[in a new window]
|
FIG. 1.
Growth characteristics of C. albicans
blastoconidia and petites 1 and 2 on agar plates. Cells were incubated
at 37°C on glucose-limited agar plates for 24 h (A) and 72 h (C) or on glycerol-limited agar plates for 24 h (B) and 72 h (D). wt, wild type.
|
|

View larger version (195K):
[in this window]
[in a new window]
|
FIG. 2.
Color differentiation of C. albicans
blastoconidia and petites 1 and 2 on an indicator plate containing
eosin Y and trypan blue. On this medium metabolically active wild-type
(wt) cells from large, pale-bluish colonies, while petite mutants grow
as small, deep-violet colonies.
|
|
Cytochrome spectra of
C. albicans wild-type cells and
petites 1 and 2 were analyzed in a dual-beam spectrophotometer at room
temperature (Fig.
3). The spectra of
wild-type cells showed peaks
characteristic for cytochrome
c
(550 nm), cytochrome
b (560 nm),
and cytochrome
aa3 (600 nm). The spectra of petites 1 and 2 lacked
absorption bands for cytochromes
b and
aa3 and indicated reduced
amounts of cytochrome
c. This result was confirmed by spectroscopic
cytochrome
analysis at

190°C (
35).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Cytochrome spectra of wild-type (wt) and petite mutant
cells. Spectra were recorded with a thick cell slurry at room
temperature in a cuvette with a 1-cm light path. AU, absorption
units.
|
|
Oxygen consumption measurements.
Respiration rates of petites
1 and 2 were compared with that of C. albicans wild-type
cells in an oxygraph at 37°C by using cell suspensions containing
5 × 106 cells · ml
1. Figure
4 shows the results of a typical
experiment. Initially, the endogenous oxygen consumption rate was
measured. During the first 5 min, wild-type cells exhibited a
relatively high endogenous oxygen consumption rate of 7.0 ± 0.45 nmol · ml
1 · min
1, which is
characteristic for C. albicans (39). With time,
endogenous oxygen consumption decreased slightly to 3.8 ± 1.0 nmol · ml
1 · min
1 and could
be stimulated again to 5.6 ± 1.5 nmol · ml
1 · min
1 by the addition of
glucose after 10 min. Compared to that of wild-type cells, the oxygen
consumption by petites 1 and 2 was negligible and the addition of
glucose could not stimulate oxygen consumption. These results provide
further evidence that petites 1 and 2 are deficient in respiration and
therefore are incapable of mitochondrial ATP synthesis.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 4.
Oxygen consumption by wild-type (wt) and petite mutant
cells. (A) Comparison of rates of oxygen consumption by wild-type and
petite mutant cells; (B) effect of inhibitors on wild-type cells. ,
glucose was added to a final concentration of 30 mM after 10 min; ,
either sodium azide or CCCP was added to a final concentration of 25 mM
or 100 µM, respectively. The decrease in oxygen concentration (conc.)
prior to additions represents endogenous consumption.
|
|
To test the effect of sodium azide and CCCP on mitochondrial activity
of
C. albicans, oxygen consumption measurements were
carried
out in the presence of these inhibitors (Fig.
4B). After
the endogenous
oxygen consumption rate was measured for the first
5 min (6.9 ± 0.44 nmol · ml
1 · min
1),
sodium azide was added to a final concentration of 25 mM, which
reduced
the respiration rate to 1.5 ± 0.44 nmol · ml
1 · min
1. In contrast, at a
concentration of 100 µM, CCCP increased the
respiration rate
approximately twofold to 14.7 ± 3.2 nmol · ml
1 · min
1. This is significantly
higher than the endogenous oxygen consumption.
The addition of glucose
after 10 min stimulated oxygen consumption
in untreated wild-type
cells, while it had no detectable effect
on sodium azide- or
CCCP-treated cells. This indicated that the
concentrations of sodium
azide and CCCP were high enough to achieve
maximum inhibition or
stimulation of respiration,
respectively.
Killing activity of histatin 5.
Histatin 5 killing efficacy
was tested with C. albicans wild-type and petite mutant 1 and 2 cells. Killing assays were carried out at 37°C with histatin 5 concentrations ranging from 0 to 131 nmol · ml
1 (0 to 400 µg · ml
1). Exposure of wild-type cells to
histatin 5 resulted in a typical dose-response curve which reached a
maximum of 98% killing at the highest histatin 5 concentration (Fig.
5A). Under the same experimental
conditions, histatin 5 killing activity was significantly reduced to
28% for petite 1 and 32% for petite 2 at the highest concentration
tested (Fig. 5A).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 5.
Killing activity of histatin 5. (A) Comparison of
histatin 5 activity towards wild-type ( ) and petite mutant 1 ( )
and 2 ( ) cells. (B) Killing of wild-type cells incubated in the
presence of 10 mM PPB only ( ), 25 mM sodium chloride ( ), 25 mM
sodium azide ( ), or 100 µM CCCP ( ). The data shown are means
and standard deviations from at least two experiments performed in
triplicates.
|
|
Killing of blastoconidia by histatin 5 was also tested with wild-type
cells in the presence and absence of sodium azide and
CCCP. Initial
control experiments carried out to test whether
sodium azide (25 mM)
and CCCP (100 µM) were themselves toxic showed
that these inhibitors
do not kill
C. albicans at the concentrations
employed.
Therefore, these compounds could be used to test whether
inhibition of
mitochondrial ATP synthesis would alter the susceptibility
of
C. albicans to histatin 5. When sodium azide or CCCP was included
in
the histatin 5 killing assay, the effect of histatin 5 on
C. albicans was significantly reduced (Fig.
5B). At the highest
histatin
5 concentration, only 49% of the sodium azide-treated and
56%
of the CCCP-treated cells were killed, while 98% killing occurred
in the absence of these inhibitors. To exclude the possibility
that a
salt effect could account for the reduced killing activity
observed
with sodium azide, a control experiment was carried out
in the presence
of sodium chloride at the same concentration (25
mM). Sodium chloride
reduced killing at low histatin concentrations
but caused no reduction
at 65 nmol · ml
1 (Fig.
5B). These data show that
the reduced killing observed
with sodium azide was due to its action as
a respiratory inhibitor.
In summary, our results obtained with
wild-type and petite cells
revealed that reduction of metabolic
activity decreased the susceptibility
of
C. albicans to
histatin
5.
Interaction of the cells with histatin 5.
Blastoconidia of
C. albicans wild-type cells, wild-type cells treated with 25 mM sodium azide or 100 µM CCCP, and petites 1 and 2 were incubated
with 65 nmol · ml
1 of histatin 5 at 37°C for 10, 30, and 60 min. After incubation, cell suspensions were centrifuged and
pellets and supernatants were separately analyzed by SDS-PAGE on 16%
gels. Comparing the electrophoretograms of the supernatants and
pellets, we found that a band with an electrophoretic mobility
identical to that of histatin 5 disappeared from the suspending medium
and accumulated in the cell pellets of untreated wild-type cells in a
time-dependent manner (Fig. 6A and B). In
contrast, when sodium azide was included in the assay, the vast
majority of histatin 5 remained in the supernatant even after 60 min of
incubation, and only an extremely small amount of histatin 5 could be
found in cell pellets (Fig. 6C and D). When wild-type cells were
treated with CCCP, histatin 5 partially disappeared from the
supernatant and a small amount accumulated intracellularly in a
time-dependent fashion (Fig. 6E and F). Comparing the results obtained
with CCCP (Fig. 6E and F) and untreated wild-type cells (Fig. 6A and
B), it becomes clear that CCCP significantly reduced, but did not
completely abolish, cellular uptake of histatin 5. This is in agreement
with the killing data obtained under the same conditions (Fig. 5B). The
vast majority of histatin 5 remained in the supernatant when petite 1 was incubated with this peptide. However, a small but clearly
detectable amount of histatin 5 could be found in the pellet after 10 min and showed only a minor increase in staining intensity after 60 min
(Fig. 6G and H). Identical results were obtained with petite 2 (Fig. 6I
and J). These results show that only metabolically active wild-type cells were able to completely take up histatin 5 from the suspending medium.

View larger version (119K):
[in this window]
[in a new window]
|
FIG. 6.
SDS-PAGE analysis of C. albicans incubated
with histatin 5. Cells were incubated for 10 min (lanes 1), 30 min
(lanes 2), or 60 min (lanes 3) with histatin 5 (65 nmol · ml 1) and centrifuged. The resulting supernatants (A, C,
E, G, and I) and pellets (B, D, F, H, and J) were analyzed by SDS-PAGE
on 16% gels. Lanes 4, 60-min control without histatin 5; lanes 5, histatin 5 standard (10 µg). (A and B) Untreated wild-type cells; (C
and D) wild-type cells treated with 25 mM sodium azide; (E and F)
wild-type cells treated with 100 µM CCCP; (G and H) petite 1; (I and
J) petite 2. Gels were stained with Coomassie brilliant blue R250.
|
|
 |
DISCUSSION |
Petite mutants of S. cerevisiae have been known for
many years. They occur spontaneously at a rate of 0.5% and can be
easily identified and isolated by their small colony size and inability to grow on nonfermentable substrates (34). In contrast, for a long time it was thought that petite mutants of C. albicans form only microcolonies which die before becoming visible
(5). We have successfully isolated petite mutants from
C. albicans which exhibited the same phenotypic
characteristics as the well-known petite mutants of S. cerevisiae with respect to growth pattern, oxygen consumption
rates, and cytochrome spectra. Petite mutants are unable to carry out
mitochondrial ATP synthesis because they lack cytochromes a
and b and therefore are limited to substrate-level phosphorylation to generate ATP. This reduces the amount of cellular energy that can be derived from glucose to a small fraction of that
generated by wild-type cells.
It is interesting that in the presence of sodium azide, oxygen
consumption by C. albicans wild-type cells was reduced to
almost the same extent as in petite mutants (Fig. 4). Sodium azide is a
specific inhibitor of cytochrome oxidase (42). This enzyme catalyzes the reduction of O2 to water, and therefore,
oxygen consumption by C. albicans cells was almost
completely abolished upon addition of this inhibitor (Fig. 4B). In
petite mutants, cytochrome oxidase is also not functional due to the
absence of cytochrome a. In contrast, CCCP is an uncoupler
of the membrane proton gradients and thus inhibits mitochondrial ATP
synthesis without interrupting the respiratory chain and oxygen
consumption. This results in an increased rate of oxygen consumption by
C. albicans cells upon addition of CCCP (Fig. 4B).
Treatment of cells with inhibitors or petite mutation dramatically
reduced the killing activity of histatin 5. This showed that the
effectiveness of histatin 5 depends on cellular energy. Previous
studies have shown that the activity of the cationic antimicrobial
peptides defensins against tumor cells (21), bacteria (38), and C. albicans (20) is energy
dependent. This energy dependence is explained by our current
understanding of the mechanism of cationic antimicrobial peptides, in
which a positively charged peptide first binds to the external surface
of the negatively charged phospholipid bilayer. Subsequently, two to
four peptide molecules form a channel-like structure under the
influence of the electric field induced by the membrane potential,
leading to leakage of cytoplasmic molecules and cell death (11,
40).
If the interaction of histatins with the cytoplasmic membrane of
C. albicans occurs in a similar fashion, then treatment of wild-type cells with inhibitors of ATP synthesis or petite mutations would result in reduced cellular accumulation of this peptide. This was
indeed found when cells incubated with histatin 5 were analyzed by
SDS-PAGE (Fig. 6). At a concentration of 65 nmol · ml
1 histatin 5, wild-type cells not treated with
inhibitors accumulated the largest amount of the peptide, and 98% of
the cells were killed (Fig. 5B and 6B). On the other hand, wild-type
cells treated with CCCP and sodium azide were killed at 40 and 10%,
respectively, and accumulated proportionally less histatin 5. Petites 1 and 2 displayed intermediate uptake and killing (Fig. 5A and 6G to J).
Even though the above findings imply similarities between defensins and
histatins, it cannot be concluded that the two proteins kill
microorganisms with the same mechanism. Histatins release potassium (29) magnesium (44), and ATP
(18) from C. albicans, but liberation of large
molecules, e.g., proteins and nucleic acids, has not yet been reported.
Therefore, it is unlikely that histatin 5 can form stable membrane
pores. This notion is further supported by the finding that histatin 5 treatment did not depolarize the membrane of C. albicans
(18). Additionally, specific histatin binding proteins on
the cell membrane of C. albicans have been described
(7, 44) and it has been suggested that such receptors may be
involved in histatin transport (7). The role of receptors for histatin killing activity needs further exploration, since a
histatin 5 fragment synthesized from D-amino acids kills
C. albicans as effectively as the L-isomer
(28).
In summary, our results show that inhibition of mitochondrial ATP
synthesis protected C. albicans from the fungicidal activity of histatin 5 and that this protection appeared to be due to reduced cellular accumulation of the peptide. This is in agreement with recent
findings that fluorescently labeled histatin 3 accumulated in cells of
C. albicans at 30°C but not at 0°C (44).
Therefore, it can be considered as established that energy-dependent
uptake of histatins is necessary for killing of C. albicans.
Whether histatin autonomously penetrates the cytoplasmic membrane or
uptake is mediated by a specific receptor remains unclear. The
correlation between killing and uptake of both histatin 5 (this study)
and histatin 3 (44) in the absence of obvious membrane
damage suggests that the final events in killing occur intracellularly.
For instance, studies have shown that the energized mitochondrion may
be the intracellular target of histatin 5 (12). Furthermore,
petite mutants contain only degenerated mitochondria without typical cristae (3, 17, 19). Therefore, petite mutants lack this type of intracellular target, which may reduce equilibrium-driven uptake of histatin 5. Further research is necessary to determine whether mitochondrial energy is only a preliminary requirement for
histatin 5 uptake or whether the mitochondrion is indeed the primary
intracellular target of histatin 5.
 |
ACKNOWLEDGMENTS |
We thank Fred Sherman, University of Rochester, for examining
cytochrome expression in our petite mutants at
190°C.
This work was supported in part by NIH/NICDR grants DE05672 and DE07652.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Boston
University Goldman School of Dental Medicine, Department of
Periodontology and Oral Biology, 700 Albany St. W201, Boston, MA
02118-2392. Phone: (617) 638-4727. Fax: (617) 638-4924. E-mail:
fropp{at}bu.edu.
 |
REFERENCES |
| 1.
|
Abraham, C. M.,
I. Al-Hashimi, and N. Haghighat.
1998.
Evaluation of the levels of oral Candida in patients with Sjögren's syndrome.
Oral Surg. Oral Med. Oral Radiol. Endod.
86:65-68[CrossRef][Medline].
|
| 2.
|
Abu Hatab, M. A., and P. A. Whittaker.
1992.
Isolation and characterization of respiration-deficient mutants from the pathogenic yeast Candida albicans.
Antonie Leeuwenhoek
61:207-219.
|
| 3.
|
Aoki, S., and S. Ito-Kuwa.
1987.
Induction of petite mutation with acriflavine and elevated temperature in Candida albicans.
J. Med. Vet. Mycol.
25:269-277[Medline].
|
| 4.
|
Atkinson, J. C., and P. C. Fox.
1992.
Salivary gland dysfunction.
Clin. Geriat. Med.
8:499-511[Medline].
|
| 5.
|
Bulder, C. J. E. A.
1964.
Lethality of the petite mutation in petite negative yeasts.
Antonie Leeuwenhoek
30:442-454.
|
| 6.
|
Claisse, M. L.,
G. A. Pere-Aubert,
L. P. Clavilier, and P. P. Slonimski.
1970.
Methode d'estimation de la concentration des cytochromes dans les cellules entieres de levure.
Eur. J. Biochem.
16:430-438[Medline].
|
| 7.
|
Edgerton, M.,
S. E. Koshlukova,
T. E. Lo,
B. G. Chrzan,
R. M. Straubinger, and P. A. Raj.
1998.
Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans.
J. Biol. Chem.
273:20438-20447[Abstract/Free Full Text].
|
| 8.
|
Ephrussi, B.,
H. Hottinguer, and A.-M. Chimenes.
1949.
Action de l'acriflavine sur les levures. I. La mutation "petite colonie."
Ann. Inst. Pasteur (Paris)
76:351-367.
|
| 9.
|
Faye, G.,
H. Fukuhara,
C. Grandchamp,
J. Lazowska,
F. Michel,
J. Casey,
G. S. Getz,
J. Locker,
M. Rabinowitz,
M. Bolotin-Fukuhara,
D. Coen,
J. Deutsch,
B. Dujon,
P. Netter, and P. P. Slonimski.
1973.
Mitochondrial nucleic acids in the petite colonie mutants: deletions and repetitions of genes.
Biochimie
55:779-792[Medline].
|
| 10.
|
Flury, U.,
H. R. Mahler, and F. Feldman.
1974.
A novel respiration-deficient mutant of Saccharomyces cerevisiae.
J. Biol. Chem.
249:6130-6137[Abstract/Free Full Text].
|
| 11.
|
Hancock, R. E. W.
1997.
Peptide antibiotics.
Lancet
349:418-422[CrossRef][Medline].
|
| 12.
|
Helmerhorst, E. J.,
P. Breeuwer,
W. van't Hof,
E. Walgreen-Weterings,
L. C. J. M. Oomen,
E. C. I. Veerman,
A. van Niew Amerongen, and T. Abee.
1999.
The cellular target of histatin 5 on Candida albicans is the energized mitochondrion.
J. Biol. Chem.
274:7286-7291[Abstract/Free Full Text].
|
| 13.
|
Heytler, P. G., and W. W. Prichard.
1962.
A new class of uncoupling agents carbonyl cyanide phenylhydrazones.
Biochem. Biophys. Res. Commun.
7:272-275[CrossRef][Medline].
|
| 14.
|
Ito-Kuwa, S.,
S. Aoki,
T. Watanabe,
T. Ehara, and T. Osafune.
1988.
Fluorescence microscopic studies on mitochondria and mitochondrial nucleotids in a wild-type strain and respiratory mutants of Candida albicans.
J. Med. Vet. Mycol.
26:207-217[Medline].
|
| 15.
|
Jainkittivong, A.,
D. A. Johnson, and C.-K. Yeh.
1998.
The relationship between salivary histatin levels and oral yeast carriage.
Oral Microbiol. Immunol.
13:181-187[Medline].
|
| 16.
|
Keilin, D., and E. F. Hartree.
1939.
Cytochrome and cytochrome oxidase.
Proc. R. Soc. B
127:167-191[Free Full Text].
|
| 17.
|
Kimura, A.,
Y. Tatsutomi,
H. Fukuda, and H. Morioka.
1980.
Effect of acriflavine on the hexokinase isoenzyme pattern of a yeast, Hansenula jadinii.
Biochim. Biophys. Acta
629:217-224[Medline].
|
| 18.
|
Koshlukova, S. E.,
T. L. Lloyd,
M. W. B. Araujo, and M. Edgerton.
1999.
Salivary histatin 5 induced non-lytic release of ATP from Candida albicans leading to cell death.
J. Biol. Chem.
274:18872-18879[Abstract/Free Full Text].
|
| 19.
|
Kot, E. J.,
L. J. Rolewic,
V. L. Olson, and D. O. McClary.
1975.
Growth, respiration and cytology of acetate-negative mutants of Candida albicans.
Antonie Leeuwenhoek
41:229-238.
|
| 20.
|
Lehrer, R. I.,
T. Ganz,
D. Szklarek, and M. E. Selsted.
1988.
Modulation of the in vitro candidacidal activity of human neutrophil defensins by target cell metabolism and divalent cations.
J. Clin. Invest.
81:1829-1835.
|
| 21.
|
Lichtenstein, A. K.,
T. Ganz,
T.-M. Nguyen,
M. E. Selsted, and R. I. Lehrer.
1988.
Mechanism of target cytolysis by peptide defensins. Target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity.
J. Immunol.
140:2686-2694[Abstract].
|
| 22.
|
Liu, R. P.,
T. J. Fleming,
B. B. Toth, and H. H. Keene.
1990.
Salivary flow rates in patients with head and neck cancer 0.5 and 25 years after radiotherapy.
Oral Surg. Oral Med. Oral Radiol. Endod.
70:724-729.
|
| 23.
|
Nagai, S.
1963.
Diagnostic color differentiation plates for hereditary respiration deficiency in yeast.
J. Bacteriol.
86:299-302[Abstract/Free Full Text].
|
| 24.
|
Odds, F. C.
1988.
Candida and Candidiosis, 2nd ed.
Bailliere Tindall, London, United Kingdom.
|
| 25.
|
Odds, F. C.
1991.
Morphogenesis in Candida albicans.
Crit. Rev. Microbiol.
12:45-93.
|
| 26.
|
Oksala, E.
1990.
Factors predisposing to oral yeast infections.
Acta Odontol. Scand.
48:71-74[Medline].
|
| 27.
|
Oppenheim, F. G.,
T. Xu,
F. M. McMillian,
S. M. Levitz,
R. D. Diamond,
G. D. Offner, and R. F. Troxler.
1988.
Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure and fungistatic effects on Candida albicans.
J. Biol. Chem.
263:7472-7477[Abstract/Free Full Text].
|
| 28.
| Oppenheim, F. G., T. Xu, and F. D. Roberts. May 1997. U.S. patent 5,631,228.
|
| 29.
|
Pollock, J. J.,
L. Denepitiya,
B. J. MacKay, and V. J. Iacono.
1984.
Fungistatic and fungicidal activity of human parotid saliva histidine-rich polypeptides on Candida albicans.
Infect. Immun.
44:702-707[Abstract/Free Full Text].
|
| 30.
|
Ramirez-Amador, V.,
S. Silverman,
P. Mayer,
M. Tyler, and J. Quivey.
1997.
Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy.
Oral Surg. Oral Med. Oral Radiol. Endod.
84:149-153[CrossRef][Medline].
|
| 31.
|
Rossie, K. M.,
J. Taylor,
F. M. Beck,
S. E. Hodgson, and G. G. Blozis.
1987.
Influence of radiation therapy on oral Candida albicans colonization: a quantitative assessment.
Oral Surg. Oral Med. Oral Radiol. Endod.
64:698-701.
|
| 32.
|
Roth-Ben Arie, Z.,
Z. Altboum,
I. Berdicevsky, and E. Segal.
1998.
Isolation of a petite mutant from a histidine auxotroph of Candida albicans and its characterization.
Mycopathologia
141:127-135[CrossRef][Medline].
|
| 33.
|
Scully, C.,
M. El-Kabir, and L. P. Samaranayake.
1994.
Candida and oral candidosis: a review.
Crit. Rev. Oral Biol. Med.
5:125-157[Abstract/Free Full Text].
|
| 34.
|
Sherman, F.
1967.
The preparation of cytochrome-deficient mutants of yeast.
Methods Enzymol.
10:9610-9616.
|
| 35.
|
Sherman, F., and P. P. Slonimski.
1964.
Respiration-deficient mutants of yeast.
II. Biochemistry. Biochim. Biophys. Acta
90:1-15.
|
| 36.
|
Tavlitzki, J.
1949.
Action de l'acriflavine sur les levures. III. Etude de la croissance des mutants "petite colonies."
Ann. Inst. Pasteur (Paris)
76:497-509.
|
| 37.
|
Troxler, R. F.,
G. D. Offner,
T. Xu,
J. C. van der Speck, and F. G. Oppenheim.
1990.
Structural relationship between human salivary histatins.
J. Dent. Res.
69:2-6[Abstract/Free Full Text].
|
| 38.
|
Walton, E., and G. P. Gladstone.
1976.
Factors affecting the susceptibility of staphylococci to killing by the cationic proteins from rabbit polymorphonuclear leucocytes: the effect of alteration of cellular energetics and of various iron compounds.
Br. J. Exp. Pathol.
57:560-570[Medline].
|
| 39.
|
Ward, J. M., and W. J. Nickerson.
1958.
Respiratory metabolism of normal and divisionless strains of Candida albicans.
J. Gen. Physiol.
41:703-724[Abstract/Free Full Text].
|
| 40.
|
Weinberg, A.,
S. Krisanaprakornkit, and B. A. Dale.
1998.
Epithelial antimicrobial peptides: review and significance for oral applications.
Crit. Rev. Oral Biol. Med.
9:399-414[Abstract/Free Full Text].
|
| 41.
|
Wilson, D. F.
1969.
The stoichiometry and site specificity of the uncoupling of mitochondrial oxidative phosphorylation by salicylanilide derivatives.
Biochemistry
8:2475-2481[CrossRef][Medline].
|
| 42.
|
Wilson, D. F., and B. Chance.
1967.
Azide inhibition of mitochondrial electron transport. I. The aerobic state of succinate oxidation.
Biochim. Biophys. Acta
131:421-430[Medline].
|
| 43.
|
Xu, T.,
S. M. Levitz,
R. D. Diamond, and F. G. Oppenheim.
1991.
Anticandidal activity of major human salivary histatins.
Infect. Immun.
59:2549-2554[Abstract/Free Full Text].
|
| 44.
|
Xu, Y.,
I. Ambudkar,
H. Yamagishi,
W. Swain,
T. J. Walsh, and B. C. O'Connell.
1999.
Histatin 3-mediated killing of Candida albicans: effect of extracellular salt concentration on binding and internalization.
Antimicrob. Agents Chemother.
43:2256-2262[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, February 2000, p. 348-354, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Luque-Ortega, J. R., Hof, W. v., Veerman, E. C. I., Saugar, J. M., Rivas, L.
(2008). Human antimicrobial peptide histatin 5 is a cell-penetrating peptide targeting mitochondrial ATP synthesis in Leishmania. FASEB J.
22: 1817-1828
[Abstract]
[Full Text]
-
Jang, W. S., Li, X. S., Sun, J. N., Edgerton, M.
(2008). The P-113 Fragment of Histatin 5 Requires a Specific Peptide Sequence for Intracellular Translocation in Candida albicans, Which Is Independent of Cell Wall Binding. Antimicrob. Agents Chemother.
52: 497-504
[Abstract]
[Full Text]
-
Fitzgerald-Hughes, D. H., Coleman, D. C., Connell, B. C. O
(2007). Differentially Expressed Proteins in Derivatives of Candida albicans Displaying a Stable Histatin 3-Resistant Phenotype. Antimicrob. Agents Chemother.
51: 2793-2800
[Abstract]
[Full Text]
-
Wei, G.-X., Campagna, A. N., Bobek, L. A.
(2006). Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother
57: 1100-1109
[Abstract]
[Full Text]
-
Helmerhorst, E. J., Venuleo, C., Sanglard, D., Oppenheim, F. G.
(2006). Roles of Cellular Respiration, CgCDR1, and CgCDR2 in Candida glabrata Resistance to Histatin 5. Antimicrob. Agents Chemother.
50: 1100-1103
[Abstract]
[Full Text]
-
Ouhara, K., Komatsuzawa, H., Yamada, S., Shiba, H., Fujiwara, T., Ohara, M., Sayama, K., Hashimoto, K., Kurihara, H., Sugai, M.
(2005). Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cells. J Antimicrob Chemother
55: 888-896
[Abstract]
[Full Text]
-
Baev, D., Rivetta, A., Vylkova, S., Sun, J. N., Zeng, G.-F., Slayman, C. L., Edgerton, M.
(2004). The TRK1 Potassium Transporter Is the Critical Effector for Killing of Candida albicans by the Cationic Protein, Histatin 5. J. Biol. Chem.
279: 55060-55072
[Abstract]
[Full Text]
-
Lupetti, A., Brouwer, C. P. J. M., Dogterom-Ballering, H. E. C., Senesi, S., Campa, M., van Dissel, J. T., Nibbering, P. H.
(2004). Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin. J Antimicrob Chemother
54: 603-608
[Abstract]
[Full Text]
-
Midorikawa, K., Ouhara, K., Komatsuzawa, H., Kawai, T., Yamada, S., Fujiwara, T., Yamazaki, K., Sayama, K., Taubman, M. A., Kurihara, H., Hashimoto, K., Sugai, M.
(2003). Staphylococcus aureus Susceptibility to Innate Antimicrobial Peptides, {beta}-Defensins and CAP18, Expressed by Human Keratinocytes. Infect. Immun.
71: 3730-3739
[Abstract]
[Full Text]
-
Brun, S., Aubry, C., Lima, O., Filmon, R., Berges, T., Chabasse, D., Bouchara, J.-P.
(2003). Relationships between Respiration and Susceptibility to Azole Antifungals in Candida glabrata. Antimicrob. Agents Chemother.
47: 847-853
[Abstract]
[Full Text]
-
Yeaman, M. R., Yount, N. Y.
(2003). Mechanisms of Antimicrobial Peptide Action and Resistance. Pharmacol. Rev.
55: 27-55
[Abstract]
[Full Text]
-
Bobek, L. A., Situ, H.
(2003). MUC7 20-Mer: Investigation of Antimicrobial Activity, Secondary Structure, and Possible Mechanism of Antifungal Action. Antimicrob. Agents Chemother.
47: 643-652
[Abstract]
[Full Text]
-
Lupetti, A., Paulusma-Annema, A., Senesi, S., Campa, M., van Dissel, J. T., Nibbering, P. H.
(2002). Internal Thiols and Reactive Oxygen Species in Candidacidal Activity Exerted by an N-Terminal Peptide of Human Lactoferrin. Antimicrob. Agents Chemother.
46: 1634-1639
[Abstract]
[Full Text]
-
Helmerhorst, E. J., Troxler, R. F., Oppenheim, F. G.
(2001). The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl. Acad. Sci. USA
10.1073/pnas.141366998v1
[Abstract]
[Full Text]
-
Rothstein, D. M., Spacciapoli, P., Tran, L. T., Xu, T., Roberts, F. D., Dalla Serra, M., Buxton, D. K., Oppenheim, F. G., Friden, P.
(2001). Anticandida Activity Is Retained in P-113, a 12-Amino-Acid Fragment of Histatin 5. Antimicrob. Agents Chemother.
45: 1367-1373
[Abstract]
[Full Text]
-
Sanglard, D., Ischer, F., Bille, J.
(2001). Role of ATP-Binding-Cassette Transporter Genes in High-Frequency Acquisition of Resistance to Azole Antifungals in Candida glabrata. Antimicrob. Agents Chemother.
45: 1174-1183
[Abstract]
[Full Text]
-
Lupetti, A., Paulusma-Annema, A., Welling, M. M., Senesi, S., van Dissel, J. T., Nibbering, P. H.
(2000). Candidacidal Activities of Human Lactoferrin Peptides Derived from the N Terminus. Antimicrob. Agents Chemother.
44: 3257-3263
[Abstract]
[Full Text]
-
Edgerton, M., Koshlukova, S. E., Araujo, M. W. B., Patel, R. C., Dong, J., Bruenn, J. A.
(2000). Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways. Antimicrob. Agents Chemother.
44: 3310-3316
[Abstract]
[Full Text]
-
Koshlukova, S. E., Araujo, M. W. B., Baev, D., Edgerton, M.
(2000). Released ATP Is an Extracellular Cytotoxic Mediator in Salivary Histatin 5-Induced Killing of Candida albicans. Infect. Immun.
68: 6848-6856
[Abstract]
[Full Text]
-
Helmerhorst, E. J., van't Hof, W., Breeuwer, P., Veerman, E. C. I., Abee, T., Troxler, R. F., Amerongen, A. V. N., Oppenheim, F. G.
(2001). Characterization of Histatin 5 with Respect to Amphipathicity, Hydrophobicity, and Effects on Cell and Mitochondrial Membrane Integrity Excludes a Candidacidal Mechanism of Pore Formation. J. Biol. Chem.
276: 5643-5649
[Abstract]
[Full Text]
-
Helmerhorst, E. J., Troxler, R. F., Oppenheim, F. G.
(2001). The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl. Acad. Sci. USA
98: 14637-14642
[Abstract]
[Full Text]